JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

Anesth Analg 1986; 65:601-604
© 1986 International Anesthesia Research Society
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jebeles, J. A.
Right arrow Articles by Bradley, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jebeles, J. A.
Right arrow Articles by Bradley, E. L., Jr

Spinal and Supraspinal Mechanisms for Morphine-Pentobarbital Antinociceptive Interaction in Relation to Cardiac Acceleration Response in Rats

John A. Jebeles, BS, Igor Kissin, MD, PhD, and Edwin L. Bradley, Jr, PhD

Received from the Department of Anesthesiology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.

Abstract

In rat experiments, morphine-pentobarbital antinociceptive interaction affecting cardiac acceleration in response to somatic noxious stimulation was analyzed with the use of intrathecal and intracerebroventricular injections of morphine. Cardiac acceleration response was induced by tail compression, and heart rate was monitored by electrocardiogram. Pentobarbital, in a subanesthetic intravenous dose, antagonized the antinociceptive effect of morphine in relation to cardiac acceleration response when morphine was administered intracerebroventricularly. Without pentobarbital, morphine, 8 µg, almost completely blocked the cardiac acceleration response, which was only 1 ± 1 beats/mm. When pentobarbital (10 mg/kg intravenously) was administered in a combination with the same dose of morphine, the cardiac acceleration response was 29 ± 3 beats/min (P < 0.0001). In contrast, when morphine was administered intrathecally, the antagonism by pentobarbital of the cardiac acceleration response was absent. The results suggest that supraspinal mechanisms play a decisive role in morphine-pentobarbital antagonism in relation to cardiac acceleration response to somatic noxious stimulation.

Key Words: ANALGESICS—morphine • HYPNOTICS, BARBITURATES—pentobarbital • PAIN—vascular responses




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
L. Groban, J. C. Vernon, and J. Butterworth
Intrathecal Morphine Reduces Infarct Size in a Rat Model of Ischemia-Reperfusion Injury
Anesth. Analg., April 1, 2004; 98(4): 903 - 909.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. J. Rady, W. Lin, and J. M. Fujimoto
Pentobarbital Antagonism of Morphine Analgesia Mediated by Spinal Cholecystokinin
J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 878 - 885.
[Abstract] [Full Text]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1986 by the International Anesthesia Research Society.